Looking for 3 fast-growing ASX shares to invest in and beat the S&P/ASX 200 (INDEXASX: XJO) index? Consider these three companies below.
Nanosonics Ltd (ASX: NAN)
Nanosonics manufacturers the Trophon EPR ultrasound probe disinfector and its related consumables. Nanosonics is seen similar to the Gillette model as customers buy the Trophon EPR system (the razor), then buy consumables (blades) which are high margin and recurring.
You can read more about Nanosonics’ impressive half-year results here, along with Andrew Page’s coverage from strawman.com.
CSL Ltd (ASX: CSL)
CSL is Australia’s largest healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Government to Australian investors in 1994 at $2.30 per share. Today, CSL is a global leader in blood plasma vaccines and antivenoms, providing relief for potentially life-threatening medical conditions.
You can see CSL’s half-year results here or get Rask Media’s view of whether it may (or may not) be the right time to buy.
Cochlear Ltd (ASX: COH)
Cochlear is one of the world’s leading medical business. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years.
Cochlear is a very impressive business double-digit sales and profit growth, which you can find here.
[ls_content_block id=”14947″ para=”paragraphs”]
